Article Information
vol. 7 no. 302 302ra136
- Received for publication July 2, 2015
- Accepted for publication August 5, 2015
- .
Author Information
- Laura R. Saunders1,
- Alexander J. Bankovich1,
- Wade C. Anderson1,
- Monette A. Aujay1,
- Sheila Bheddah1,
- KristenAnn Black1,
- Radhika Desai1,
- Paul A. Escarpe1,
- Johannes Hampl1,
- Amy Laysang1,
- David Liu1,
- Javier Lopez-Molina1,
- Milly Milton1,
- Albert Park1,
- Marybeth A. Pysz1,
- Hui Shao1,
- Brian Slingerland1,
- Michael Torgov1,*,
- Samuel A. Williams1,
- Orit Foord1,
- Philip Howard2,
- Jacek Jassem3,
- Andrzej Badzio3,
- Piotr Czapiewski3,
- David H. Harpole4,
- Afshin Dowlati5,
- Pierre P. Massion6,
- William D. Travis7,
- M. Catherine Pietanza7,8,
- J. T. Poirier7,8,
- Charles M. Rudin7,
- Robert A. Stull1 and
- Scott J. Dylla1,†
- 1Stemcentrx Inc., South San Francisco, CA 94080, USA.
- 2Spirogen (a member of the AstraZeneca Group), London W2 6BD, UK.
- 3Medical University of Gdańsk, Gdańsk 82-300, Poland.
- 4Duke University Medical Cancer, Durham, NC 27710, USA.
- 5Case Western Reserve University and University Hospitals Seidman Cancer Center, Cleveland, OH 44106, USA.
- 6Thoracic Program, Vanderbilt-Ingram Cancer Center, Tennessee Valley Healthcare Systems, Nashville Campus, Nashville, TN 37232, USA.
- 7Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
- 8Weill Cornell Medical College, New York, NY 10065, USA.
- ↵†Corresponding author. E-mail: scott.dylla{at}stemcentrx.com